Price $42.69 |
Market Cap
59.35B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
44.9
|
P/B
6.31
|
P/S
5.9
|
Dividend %
-
|
|
P/CF
32.9
|
P/FCF
73.0
|
Op. Cash Flow
1.16M
|
FCF
0.5
|
|
Op. Margin
16.20%
|
Net Margin
13.90%
|
ROE
15.70%
|
ROI
10.70%
|
|
ROA
6.20%
|
EPS Growth
167.30%
|
Current Ratio
0.8
|
Debt/Equity
55.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| MTBC Inc (MTBC) | $4.52 | - | - | 58.6M | Strong Buy |
| Lannett Company, Inc. (LCI) | $6.86 | - | - | 258.4M | Strong Buy |
| IRIDEX Corporation (IRIX) | $2.55 | - | - | 47.2M | Strong Buy |
| Apollo Endosurgery Inc (APEN) | $3.32 | - | - | 61.4M | Strong Buy |
| Assertio Therapeutics Inc (ASRT) | $1.52 | - | - | 208.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
